Minji Kim

Minji Kim

Auto-generated profile, based on publicly available information

Minji Kim

Laboratory of Molecular Function of Food, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, Japan

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MKMinji Kim
Minji Kim
TGTsuyoshi Goto
Tsuyoshi Goto
RYRina Yu
Rina Yu
KUKunitoshi Uchida
Kunitoshi Uchida
MTMakoto Tominaga
Makoto Tominaga
TKTeruo Kawada
Teruo Kawada
Brown adipose tissue (BAT) plays a central role in regulating energy homeostasis and may provide novel strategies for the treatment of human obesity. BAT-mediated thermogenesis is regulated by mitochondrial uncoupling protein 1 (UCP1) in classical brown and ectopic beige adipocytes and is controlled by sympathetic nervous system (SNS). Previous work indicated that fish oil intake reduces fat accumulation and induces UCP1 expression in BAT; however, the detailed mechanism of this effect remains unclear. In this study, we investigated the effect of fish oil on energy expenditure and the SNS. Fish oil intake increased oxygen consumption and rectal temperature, with concomitant upregulation of UCP1 and the β3 adrenergic receptor (β3AR), two markers of beige adipocytes, in the interscapular BAT and inguinal white adipose tissue (WAT). Additionally, fish oil intake increased the elimination of urinary catecholamines and the noradrenaline (NA) turnover rate in interscapular BAT and inguinal WAT. Furthermore, the effects of fish oil on SNS-mediated energy expenditure were abolished in transient receptor potential vanilloid 1 (TRPV1) knockout mice. In conclusion, fish oil intake can induce UCP1 expression in classical brown and beige adipocytes via the SNS, thereby attenuating fat accumulation and ameliorating lipid metabolism.

15 January 2012 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
PDF file
JLJoo-Young Lee
Joo-Young Lee
Nobuyuki TakahashiNobuyuki Takahashi
Nobuyuki Takahashi
MYMidori Yasubuchi
Midori Yasubuchi
YKYoung-Il Kim
Young-Il Kim
HHHikari Hashizaki
Hikari Hashizaki
TKTeruo Kawada
Teruo Kawada
Uncoupling protein (UCP)-1 expressed in brown adipose tissue plays an important role in thermogenesis. Recent data suggest that brown-like adipocytes in white adipose tissue (WAT) and skeletal muscle play a crucial role in the regulation of body weight. Understanding of the mechanism underlying the increase in UCP-1 expression level in these organs should, therefore, provide an approach to managing obesity. The thyroid hormone (TH) has profound effects on mitochondrial biogenesis and promotes the mRNA expression of UCP in skeletal muscle and brown adipose tissue. However, the action of TH on the induction of brown-like adipocytes in WAT has not been elucidated. Thus we investigate whether TH could regulate UCP-1 expression in WAT using multipotent cells isolated from human adipose tissue. In this study, triiodothyronine (T3) treatment induced UCP-1 expression and mitochondrial biogenesis, accompanied by the induction of the CCAAT/enhancer binding protein, peroxisome proliferator-activated receptor-γ coactivator-1α, and nuclear respiratory factor-1 in differentiated human multipotent adipose-derived stem cells. The effects of T3 on UCP-1 induction were dependent on TH receptor-β. Moreover, T3 treatment increased oxygen consumption rate. These findings indicate that T3 is an active modulator, which induces energy utilization in white adipocytes through the regulation of UCP-1 expression and mitochondrial biogenesis. Our findings provide evidence that T3 serves as a bipotential mediator of mitochondrial biogenesis.

1 January 2016 in Cytokine
Verified
Journal Article
Closed access
TGTsuyoshi Goto
Tsuyoshi Goto
SNSupaporn Naknukool
Supaporn Naknukool
RYRieko Yoshitake
Rieko Yoshitake
YHYuki Hanafusa
Yuki Hanafusa
STSoshi Tokiwa
Soshi Tokiwa
TKTeruo Kawada
Teruo Kawada

28 July 2017 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
MKMinji Kim
Minji Kim
TFTomoya Furuzono
Tomoya Furuzono
KYKanae Yamakuni
Kanae Yamakuni
YLYongjia Li
Yongjia Li
YKYoung‐Il Kim
Young‐Il Kim
TGTsuyoshi Goto
Tsuyoshi Goto
Gut microbiota can regulate the host energy metabolism; however, the underlying mechanisms that could involve gut microbiota–derived compounds remain to be understood. Therefore, in this study, we investigated the effects of KetoA [10‐oxo‐12( Z )‐octadecenoic acid]—a linoleic acid metabolite produced by gut lactic acid bacteria—on whole‐body energy metabolism and found that dietary intake of KetoA could enhance energy expenditure in mice, thereby protecting mice from diet‐induced obesity. By using Ca 2+ imaging and whole‐cell patch‐clamp methods, KetoA was noted to potently activate transient receptor potential vanilloid 1 (TRPV1) and enhance noradrenalin turnover in adipose tissues. In addition, KetoA up‐regulated genes that are related to brown adipocyte functions, including uncoupling protein 1 (UCP1) in white adipose tissue (WAT), which was later diminished in the presence of a β‐adrenoreceptor blocker. By using obese and diabetic model KK‐Ay mice, we further show that KetoA intake ameliorated obesity‐associated metabolic disorders. In the absence of any observed KetoA‐induced antiobesity effect or UCP1 up‐regulation in TRPV1‐deficient mice, we prove that the antiobesity effect of KetoA was caused by TRPV1 activation‐mediated browning in WAT. KetoA produced in the gut could therefore be involved in the regulation of host energy metabolism.—Kim, M., Furuzono, T., Yamakuni, K., Li, Y., Kim, Y.‐I., Takahashi, H., Ohue‐Kitano, R., Jheng, H.‐F., Takahashi, N., Kano, Y., Yu, R., Kishino, S., Ogawa, J., Uchida, K., Yamazaki, J., Tominaga, M., Kawada, T., Goto, T. 10‐oxo‐12(Z)‐octadecenoic acid, a linoleic acid metabolite produced by gut lactic acid bacteria, enhances energy metabolism by activation of TRPV1. FASEB J. 31, 5036–5048 (2017). www.fasebj.org

11 February 2016 in EMBO Reports
Verified
Journal Article
Open access
PDF file
WSWuping Sun
Wuping Sun
KUKunitoshi Uchida
Kunitoshi Uchida
YSYoshiro Suzuki
Yoshiro Suzuki
YZYiming Zhou
Yiming Zhou
MKMinji Kim
Minji Kim
MTMakoto Tominaga
Makoto Tominaga
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 June 2017 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TGTsuyoshi Goto
Tsuyoshi Goto
MHMariko Hirata
Mariko Hirata
YAYumeko Aoki
Yumeko Aoki
MIMari Iwase
Mari Iwase
HTHaruya Takahashi
Haruya Takahashi
TKTeruo Kawada
Teruo Kawada
Obesity causes excess fat accumulation in white adipose tissues (WAT) and also in other insulin-responsive organs such as the skeletal muscle, increasing the risk for insulin resistance, which can lead to obesity-related metabolic disorders. Peroxisome proliferator-activated receptor-α (PPARα) is a master regulator of fatty acid oxidation whose activator is known to improve hyperlipidemia. However, the molecular mechanisms underlying PPARα activator-mediated reduction in adiposity and improvement of metabolic disorders are largely unknown. In this study we investigated the effects of PPARα agonist (fenofibrate) on glucose metabolism dysfunction in obese mice. Fenofibrate treatment reduced adiposity and attenuated obesity-induced dysfunctions of glucose metabolism in obese mice fed a high-fat diet. However, fenofibrate treatment did not improve glucose metabolism in lipodystrophic A-Zip/F1 mice, suggesting that adipose tissue is important for the fenofibrate-mediated amelioration of glucose metabolism, although skeletal muscle actions could not be completely excluded. Moreover, we investigated the role of the hepatokine fibroblast growth factor 21 (FGF21), which regulates energy metabolism in adipose tissue. In WAT of WT mice, but not of FGF21-deficient mice, fenofibrate enhanced the expression of genes related to brown adipocyte functions, such as Ucp1, Pgc1a, and Cpt1b. Fenofibrate increased energy expenditure and attenuated obesity, whole body insulin resistance, and adipocyte dysfunctions in WAT in high-fat-diet-fed WT mice but not in FGF21-deficient mice. These findings indicate that FGF21 is crucial for the fenofibrate-mediated improvement of whole body glucose metabolism in obese mice via the amelioration of WAT dysfunctions.